| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.807 | 27.948 | 19.230 | 25.840 | 22.091 | 14.974 | 23.514 | 29.544 | 32.116 | 29.046 |
| Total Income - EUR | 22.037 | 28.097 | 19.444 | 25.914 | 22.420 | 16.070 | 23.535 | 29.544 | 33.126 | 29.775 |
| Total Expenses - EUR | 20.636 | 19.203 | 21.593 | 24.878 | 25.571 | 23.197 | 26.817 | 29.748 | 31.369 | 37.485 |
| Gross Profit/Loss - EUR | 1.400 | 8.893 | -2.149 | 1.036 | -3.151 | -7.127 | -3.282 | -204 | 1.757 | -7.710 |
| Net Profit/Loss - EUR | 739 | 8.331 | -2.343 | 777 | -3.375 | -7.272 | -3.447 | -396 | 1.432 | -8.523 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Donamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 27.226 | 26.812 | 24.928 | 23.249 | 22.004 | 24.216 | 22.481 | 21.349 | 20.087 | 20.641 |
| Current Assets | 33.970 | 37.040 | 28.861 | 21.409 | 18.670 | 14.809 | 13.904 | 15.269 | 19.295 | 19.371 |
| Inventories | 0 | 0 | 0 | 183 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 448 | 2.486 | 601 | 612 | 731 | 1.639 | 1.427 | 1.307 | 2.285 | 2.884 |
| Cash | 33.522 | 34.554 | 28.260 | 20.614 | 17.939 | 13.170 | 12.477 | 13.962 | 17.010 | 16.487 |
| Shareholders Funds | 20.959 | 29.076 | 26.241 | 26.536 | 22.647 | 14.946 | 11.167 | 10.805 | 12.205 | 3.614 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.238 | 34.776 | 27.548 | 18.122 | 18.027 | 24.079 | 25.218 | 25.812 | 27.176 | 36.398 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Donamed S.r.l.